News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pancreatic Cancer Biotech GlobeImmune, Inc. Sets Terms For $35 Million In Second IPO Attempt


4/30/2014 7:03:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlobeImmune has taken a big step forward in its second attempt to go public. Now the question is whether the Louisville, CO-based biotech will get to the finish line this time around. According to a regulatory filing posted by the company on Tuesday, GlobeImmune intends to price its shares between $15 and $17 apiece and sell 2,187,500 shares total at its IPO. GlobeImmune would pocket $32.8 million at $15 per share, and nearly $37.2 million if it reaches the $17 target.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES